Business
Enanta Pharmaceuticals to Participate in September Investor Conferences
WATERTOWN, Mass., August 21, 2025--Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA), a clinical-stage biotechnology company dedicated to creating small molecule drugs for viral infections and immunological diseases, today announced that members of management will participate in three investor conferences in September:
About this update from Enanta Pharmaceuticals, Inc.
[{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":2190,"height":732,"url":"https://media.zenfs.com/en/business-wire.com/9666fbd175a5c138abc20dcaf60bfd72"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/yL0Re9Hq5HR1meIQJmqSAw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTMyMTtjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/9666fbd175a5c138abc20dcaf60bfd72","width":960,"height":321},"lightbox":{"url":"https://s.yimg.com/ny/api/res/1.2/lcO5KJyG7CQVeteL6OTx2A--/YXBwaWQ9aGlnaGxhbmRlcjt3PTI0MDA7aD04MDI7Y2Y9d2VicA--/https://media.zenfs.com/en/business-wire.com/9666fbd175a5c138abc20dcaf60bfd72","width":1200,"height":401}},"lazy":false},{"type":"text","content":"WATERTOWN, Mass., August 21, 2025--(BUSINESS WIRE)--Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA), a clinical-stage biotechnology company dedicated to creating small molecule drugs for viral infections and immunological diseases, today announced that members of management will participate in three investor conferences in September:","length":330,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"Cantor Global Healthcare Conference 2025: Fireside Chat on Wednesday, September 3, 2025 at 8:35 a.m. ET","length":103,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"H.C. Wainwright 27th Annual Global Investment Conference: Fireside Chat on Tuesday, September 9, 2025 at 2:00 p.m. ET","length":117,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"Baird 2025 Global Healthcare Conference: Fireside Chat on Wednesday, September 10, 2025 at 12:15 p.m. ET","length":104,"tagName":"p","attribs":{}}]}],"tagName":"ul","bulletedList":true,"length":324,"olType":false},{"type":"text","content":"A live webcast of each event will be accessible by visiting the "Events and Presentations" section on the "Investors" page of Enanta’s website at www.enanta.com. A replay of the webcasts will be available following the presentation and will be archived for at least 30 days.","length":294,"tagName":"p"},{"type":"text","content":"About Enanta Pharmaceuticals, Inc.Enanta is using its robust, chemistry-driven approach and drug discovery capabilities to become a leader in the discovery and development of small molecule drugs with an emphasis on indications in virology ...